MARKSANS PHARMA
Back to Income Statement
|
MARKSANS PHARMA Last 5 Year Total Expenditure History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Expenditure | ₹2,090 Cr | ₹1,719 Cr | ₹1,513 Cr | ₹1,232 Cr | ₹1,037 Cr |
What is the latest Total Expenditure of MARKSANS PHARMA ?
| Year | Total Expenditure |
|---|---|
| Mar2026 | ₹2,090 Cr |
| Mar2025 | ₹1,719 Cr |
| Mar2024 | ₹1,513 Cr |
| Mar2023 | ₹1,232 Cr |
| Mar2022 | ₹1,037 Cr |
How is Total Expenditure of MARKSANS PHARMA Trending?
| Years | Total Expenditure | % Change | |
|---|---|---|---|
| Mar2026 | ₹2,090 Cr | 21.60 | |
| Mar2025 | ₹1,719 Cr | 13.62 | |
| Mar2024 | ₹1,513 Cr | 22.80 | |
| Mar2023 | ₹1,232 Cr | 18.85 | |
| Mar2022 | ₹1,037 Cr | - | |
Compare Total Expenditure of peers of MARKSANS PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MARKSANS PHARMA | ₹14,439.0 Cr | -2.7% | 20.9% | 75.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹459,952.0 Cr | 1% | -2.9% | 17.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹230,427.0 Cr | 1.8% | 17% | 39.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,141.0 Cr | -1.9% | -1.9% | 33.2% | Stock Analytics | |
| CIPLA | ₹114,715.0 Cr | 0.3% | 0.7% | -7.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹99,409.9 Cr | 1.7% | 3.5% | -4.1% | Stock Analytics | |
MARKSANS PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MARKSANS PHARMA | -2.7% |
20.9% |
75.7% |
| SENSEX | 0.5% |
2.1% |
-4.5% |
You may also like the below Video Courses